The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
...check out the trade at 12:40:02. We can all sleep easy tonight!
MM games - simple. I know this isn't an AIM stock, but it's behaving exactly like one. 1.54p to buy. Bargain.
Indeed, a 52-week low, but based on what? It seems to me there are a couple of things to note here. First, volume today is pretty insignificant (8m shares traded so far, but nearly a billion shares in issue). Hardly a sign that it's time to vacate Dodge, wouldn't you agree? Secondly, a lot of posters bemoaning the SP performance seem to be part of the "get rich quick" brigade. They have no patience, no stomach for the fight. I looked at a few of their posting histories and they're all posting on NNN (ffs!). That share is a complete basket case. You might as well play the roulette wheel at your local casino. And that's the point, isn't it? If you do your research, and believe in the science, these day-to-day price movements matter little. The biotech sector is not for the faint-hearted, nor really for the day trader for the most part, but it does reward the "buy and hold" investor. AIMHO.
MMs having a field day, hoovering up shares on the cheap from panic-stricken investors. Smells like someone's filling a large buy order in the background and anyone lured into selling has just been fleeced. Did you have any trouble obtaining a quote to sell, out of interest?
I was 70% down with my SAR holding at one point. I held, added more as it drifted lower. Now I'm up 500%. SAR and HEMO are not too dissimilar, imo. Patience is the key, I honestly believe. Trust the science, and the market will catch up in time.
Mickey, you're coming through "allowed" and clear!
I refer you to your own post, dated 29 Nov, 2021, 16:04.
This might resonate with some:
https://www.reddit.com/r/weedstocks/comments/1xydch/market_maker_speaks_out_ways_of_a_market_maker/
Brent, old boy, with biotech companies it's usually the science that does the talking. By the way, my broker fee is 8 quid per trade and your worried about paying that? How many shares do you hold? 100? Lol!!
Brent, if you really think this share is a 'write off', then why not sell out now, salvage something, and do us all a favour? Jeez.
linandy, you could be right, but volume has been thin. Net sales from Friday and today total a mere 1.5m shares (based on figures provided by LSE). It smells to me more of price manipulation, flushing out the weak hands. In the last month, we're down almost 20%, yet the daily average volume is only 675k shares traded. Hardly a stampede for the exit when you remember there are 922m shares in issue. Even if every one of those 675k shares were sells (which of course they weren't), over the last month, 20m shares would have been sold i.e. roughly 2% of the company, yet we've lost 20% of our market cap? Something doesn't add up, that's for sure. What it all means, maybe someone can enlighten me! P.S. Today has been carnage on the markets generally, don't forget. Placement, or not, I'm holding firm regardless.
Why the urge to post on a bulletin board, when you're not even invested there?
#odiouslittleman
Quietly confident? The loudest voice in the room is also the most insecure.
Buying op. AISC have been high thus far (as much as $1,750 per ounce), but are projected to decrease significantly in 2022. Not much downside risk from here I would have thought?
So, as someone highlighted recently, it would perhaps staunch the flow somewhat if our esteemed Board of Directors dipped their hands into their pockets and bought some shares. This got me thinking about how much Mark Warne is down already on his prior purchases (which is a lot!), and which in turn led me to this:
https://www.lse.co.uk/rns/DMTR/placing-and-subscription-to-raise-16321-million-h9qi4dd98p2ww2k.html
In my opinion, this RNS from July last year is worth another read, not least for the sections entitled 'About DeepMatter Group plc' (a great summary and compelling rationale for anyone contemplating an investment into DMTR at these current historic lows) and 'Current Trading, COVID-19 Update and Prospects' (which might go some way to explaining the SP performance of late). In this last section, we find this: "In the Directors' opinion the change to working practices within laboratories caused by social distancing is highlighting the need to share scientific data both remotely and within the lab, accelerating the digitisation of the laboratory and underlining the value proposition of the DigitalGlassware™ platform. While the uncertainty caused by COVID-19 will likely have an impact on the length of contract discussions in the short-term, the Group has a growing pipeline of sales opportunities and has seen increased interest in its DigitalGlassware™ platform and other products." It would seem to me that, as more and more companies see the economic benefits of working remotely, the technologies that DMTR is showcasing will increasingly become mainstream and in demand. But, it's a slow burner! It's not an 'in it for the short term' type of investment. Patience will be rewarded, and we need to accept that COVID-19 has created some headwinds, at least in the short term. AIMHO and GLA.
Kind of getting fatigued by these daily attacks on the SP. 9m shares traded (not even 0.3% of total shares in issue) and we're down 6.42%? Says it all really. Just urge people not to surrender in this war of attrition. All best.
Indeed, it might steady the ship somewhat, unless they're in 'closed period' discussions, and he's unable to do so? But, in principle, I totally agree with you.
Foxtrot uniform.
Trumpton, I take your point, but your math is suspect. 922m shares in issue. MW holds nearly 4m shares, correct? So that's roughly 0.4% of the company (not, as you state, 0.004%). Anyway, I like Mark. If he said what you claim about not caring regards the SP, I think that was ill-judged. But I like his enthusiasm and dynamism (being a bit of an old fossil myself, I admire the energy!). I just think DMTR are in an area that the market has difficulty understanding, and therefore quantifying. It reminds me a bit of cryptocurrencies. Old Luddites like me don't get it, but for young people it's all the rage. They are the future after all, and, just perhaps, DMTR is at the vanguard of something special and unique, also. The SP performance has clearly been a horror show of late, but I for one still back the CEO to deliver the kind of growth that will see the SP rise significantly. AIMHO. GLA.
So, my buy at 1p is showing as a sell. Not sure if that's good news for LTHs, but reiterates the fact that this website seems to be incapable of reporting trades accurately. The ratio of buys to sells, in other words, may well be skewed. Just fyi. GLA.